- Home
- RNAC vs LFCR Comparison
RNAC vs LFCR Comparison
Compare RNAC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- LFCR
- Stock Information
- Founded
- RNAC 2007
- LFCR 1986
- Country
- RNAC United States
- LFCR United States
- Employees
- RNAC N/A
- LFCR N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- RNAC Health Care
- LFCR Health Care
- Exchange
- RNAC Nasdaq
- LFCR Nasdaq
- Market Cap
- RNAC 276.3M
- LFCR 308.8M
- IPO Year
- RNAC 2016
- LFCR N/A
- Fundamental
- Price
- RNAC $10.05
- LFCR $7.61
- Analyst Decision
- RNAC Strong Buy
- LFCR Buy
- Analyst Count
- RNAC 4
- LFCR 4
- Target Price
- RNAC $40.00
- LFCR $8.00
- AVG Volume (30 Days)
- RNAC 48.4K
- LFCR 108.3K
- Earning Date
- RNAC 08-07-2025
- LFCR 08-07-2025
- Dividend Yield
- RNAC N/A
- LFCR N/A
- EPS Growth
- RNAC N/A
- LFCR N/A
- EPS
- RNAC N/A
- LFCR N/A
- Revenue
- RNAC $1,026,000.00
- LFCR $128,867,000.00
- Revenue This Year
- RNAC N/A
- LFCR $4.78
- Revenue Next Year
- RNAC N/A
- LFCR $12.02
- P/E Ratio
- RNAC N/A
- LFCR N/A
- Revenue Growth
- RNAC N/A
- LFCR 0.47
- 52 Week Low
- RNAC $8.46
- LFCR $3.68
- 52 Week High
- RNAC $26.50
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- RNAC 34.71
- LFCR 53.94
- Support Level
- RNAC $10.50
- LFCR $7.33
- Resistance Level
- RNAC $11.80
- LFCR $7.73
- Average True Range (ATR)
- RNAC 0.56
- LFCR 0.30
- MACD
- RNAC -0.11
- LFCR 0.03
- Stochastic Oscillator
- RNAC 0.45
- LFCR 65.33
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.